Product Images Arixtra
View Photos of Packaging, Labels & Appearance
- Figure 1 and 2 - image 01
- Figure 3 and 4 - image 02
- Fondaparinux Sodium Structural Formula - image 03
- arixtra-syringe-1 - image 04
- arixtra-syringe-2 - image 05
- arixtra-syringe-3 - image 06
- arixtra-figure-a - image 07
- arixtra-figure-b - image 08
- arixtra-figure-c - image 09
- arixtra-figure-d - image 10
- arixtra-figure-e - image 11
- arixtra-figure-f - image 12
- Arixtra Injection 2.5 mg/0.5 mL Carton Label - image 13
- Arixtra Injection 5 mg/0.4 mL Carton Label - image 14
- Arixtra Injection 7.5 mg/0.6 mL Carton Label - image 15
- Arixtra Injection 10 mg/0.8 mL Carton Label - image 16
Product Label Images
The following 16 images provide visual information about the product associated with Arixtra NDC 67457-595 by Mylan Institutional Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 and 2 - image 01
Figure 3 and 4 - image 02
Fondaparinux Sodium Structural Formula - image 03
arixtra-syringe-1 - image 04
arixtra-syringe-2 - image 05
arixtra-syringe-3 - image 06
arixtra-figure-a - image 07
arixtra-figure-b - image 08
arixtra-figure-c - image 09
arixtra-figure-d - image 10
arixtra-figure-e - image 11
arixtra-figure-f - image 12
Arixtra Injection 2.5 mg/0.5 mL Carton Label - image 13
This is a product description of a medication called fondaparinux sodium injection, USP, used for subcutaneous injection. This medication contains 10 single-dose prefilled syringes with an automatic needle protection system. The text also includes a warning for the pharmacist to dispense the accompanying patient information leaflet to each patient. The rest of the text appears to contain code numbers and irrelevant characters.*
Arixtra Injection 5 mg/0.4 mL Carton Label - image 14
Arixtra Injection 7.5 mg/0.6 mL Carton Label - image 15
This is a description of a medication named "Fondaparinux Sodium Injection, USP", indicated for subcutaneous injection and being sold in a package containing 10 prefilled syringes with an automatic needle protection system. The package's lot number and expiration date can be found on it. There is also a recommendation for storing the medication at room temperature (20°C to 25°C) and for dispensing a patient information leaflet to each patient. The rest of the text is not legible.*
Arixtra Injection 10 mg/0.8 mL Carton Label - image 16
This text appears to be a label for a medication called Fondaparinux Sodium Injection, prescribed for subcutaneous injection. The label includes dosage information (0°C BEF to 8 893 USP Corfrolid Foom Temperstre), instructions for pharmacists (to dispense patient information leaflets), and details about the packaging (10 single-dose, prefilled syringes with an automatic needle protection system). It also includes the NDC code (67467-595-08) for the medication as well as manufacturer information (Mylan) and lot and expiration details.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
